These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2067709)

  • 1. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases].
    Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E
    Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
    Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G
    Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of non-ulcer dyspepsia].
    Cortese I; Maselli MA
    Clin Ter; 1990 Apr; 133(2):103-7. PubMed ID: 2140745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis].
    Scalon P; Di Mario F; Meggiato T; Basso D; Battaglia G; Vianello F; Fogar P; Del Favero G
    Minerva Gastroenterol Dietol; 1992; 38(2):101-4. PubMed ID: 1391144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
    Sawant P; Das HS; Desai N; Kalokhe S; Patil S
    J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisapride: clinical experience in 1071 patients with non-ulcer dyspepsia or reflux symptoms].
    Fehr HF
    Schweiz Med Wochenschr; 1991 Jun; 121(22):843-6. PubMed ID: 2063165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
    Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
    Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
    Corazza GR; Biagi F; Albano O; Bianchi Porro G; Cheli R; Mazzacca G; Miglio F; Naccarato R; Quaglino D; Surrenti C; Verme G; Gasbarrini G
    Ital J Gastroenterol; 1996; 28(6):317-23. PubMed ID: 8891846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of gastrointestinal motility disorders].
    Jia B
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.
    Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C
    Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Levosulpiride versus domperidone in the treatment of functional dyspepsia].
    Mangiameli A; Brogna A; Catanzaro R; Sofia M; Blasi A
    Clin Ter; 1994 Feb; 144(2):107-14. PubMed ID: 7910127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying.
    Bekhti A; Rutgeerts L
    Postgrad Med J; 1979; 55 Suppl 1():30-2. PubMed ID: 382151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Major gastrointestinal syndromes (2): dyspepsia or syndrome of the upper digestive system related with food (2)].
    León-Barúa R; Berendson-Seminario R
    Rev Gastroenterol Peru; 2008; 28(3):267-9. PubMed ID: 18958143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
    De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
    Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.